Sign in

Tov Kormanon

Research Analyst at Craig-Hallum Capital Group

Tov Kormanon is an Analyst at Craig-Hallum Capital Group, specializing in equity research with a focus on the healthcare sector and small-cap companies. He has specifically covered companies such as Champions Oncology, providing investment insights and participating in quarterly earnings calls to analyze company performance and market outlook. Kormanon's research approach is shaped by Craig-Hallum's stock-picking, research-centric culture, and he is known for engaging with corporate management to deliver actionable investment ideas. While detailed public metrics on his analyst success rates or historical rankings are not available, his active participation in earnings discussions and role within Craig-Hallum's respected analyst team underscore his expertise on small-cap healthcare equities.

Tov Kormanon's questions to CHAMPIONS ONCOLOGY (CSBR) leadership

Question · Q1 2026

Tov Kormanon asked for insights into the broader investment landscape and current customer trends, and whether the stabilization period for revenue and margin expansion is expected in the first or second half of the fiscal year.

Answer

CEO Rob Brainin described the investment environment as still tough but expressed cautious optimism about improving market conditions and easing budget constraints. CFO David Miller indicated that Q1 fiscal 2026 was likely the low point for revenue, anticipating sequential expansion, with the timing of data deals being a key variable for the year's trajectory.

Ask follow-up questions

Get Instant Answers from SEC Filings & Earnings Calls

Ask complex financial questions and get precise answers in seconds. Fintool scans millions of documents to surface insights beyond timely human analysis.

Search across 8,000+ companies
Access millions of SEC filings & transcripts
Get answers cited to the source
Try Fintool for Free

Trusted by leading investment firms and analysts